Journals / MN Kardiyoloji / 2006 / Cilt: 13 - Sayı: 5

Effects of thyroid hormone replacement therapy on left ventricular systolic and diastolic function in patients with subclinical hypothyroidism

Subklinik hipotiroidizmli hastalarda tiroid hormon replasman tedavisinin sol ventrikül sistolik ve diyastolik fonksiyonları üzerine etkisi

Pages
304–311
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: L-T4 therapy for SH may be useful in preventing both progression to overt hypothyroidism and clinically important myocardial dysfunction.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Although subclinical hypothyroidism (SH) is a common condition, L-thyroxine therapy (L-T4) for SH is controversial.
📊
Key Findings & Data:We aimed to determine the effect of L-T4 therapy on left ventricular functions Material and Methods: The study group consisted of 53 patients with SH and 25 healthy controls.
💡
Conclusion & Impact:Conclusion: L-T4 therapy for SH may be useful in preventing both progression to overt hypothyroidism and clinically important myocardial dysfunction.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tiroksin · Ekokardiyografi · Hipotiroidi

Abstract

Aim: Although subclinical hypothyroidism (SH) is a common condition, L-thyroxine therapy (L-T4) for SH is controversial. We aimed to determine the effect of L-T4 therapy on left ventricular functions Material and Methods: The study group consisted of 53 patients with SH and 25 healthy controls. Besides conventional echocardiographic parameters, left ventricular preejection and ejection phases, mitral diastolic filling parameters, pulsed wave tissue Doppler velocities, myocardial precontraction, contraction and relaxation times, left ventricular stroke volume, mass and systemic vascular resistance were assessed and compared between patients and controls. L-T4 therapy was initiated for SH patients. The measurements were reassessed six months after euthyroidism is achieved. Results: Early and late transmitral inflow velocities and deceleration time did not change with L-T4 therapy whereas isovolumetric relaxation time decreased. Preejection time decreased and ejection phase increased after L-T4 therapy. Tissue Doppler echocardiographic examination revealed a decrease in myocardial precontraction and relaxation times, an increase in myocardial contraction time and no change in systolic and diastolic velocities after L-T4 therapy. Left ventriculer mass, stroke volume and systemic vascular resistance did not change after the therapy. Conclusion: L-T4 therapy for SH may be useful in preventing both progression to overt hypothyroidism and clinically important myocardial dysfunction.

Özet

Amaç: Subklinik hipotirodizm (SH) genel populasyonu yaygın olarak etkilemesine rağmen L-thyroxine (L-T4) tedavisinin kullanımı tartışmalıdır. L-T4 tedavisinin sol ventrikül fonksiyonları üzerine olan etkisini belirlemek amacıyla bu çalışma planlandı. Gereç ve Yöntem: SH’lı 53 hasta ve 25 kişilik kontrol grubu çalışmaya alındı. Konvansiyonal ekokardiyografik parametrelere ek olarak sol ventrikül preejeksiyon ve ejeksiyon fazları, mitral diyastolik doluş örnekleri, pulsed wave doku Doppler hızları, miyokardiyal prekontraksiyon, kontraksiyon ve relaksasyon zamanları, sol ventrikül atım volümü ve kütlesi ile sistemik vasküler rezistans gibi çeşitli ekokardiyografik parametreler hasta ve kontrol grubunda ölçülerek karşılaştırıldı. Daha sonra SH’lı hastalara L-T4 tedavisi başlanarak ötiroidizm sağlandıktan 6 ay sonra ölçümler tekrarlandı ve bazal değerler ile karşılaştırıldı. Bulgular: Erken ve geç transmitral akım hızlarında ve deselerasyon zamanında L-T4 tedavisi sonrası farklılık izlenmezken isovolumik relaksasyon zamanı kısaldı. Tedavi sonrası preejeksiyon peryodunda kısalma, ejeksiyon peryodunda uzama izlendi. Doku Doppler ekokardiyografide tedavi sonrası miyokardiyal prekontraksiyon zamanı ve relaksasyon zamanında kısalma, miyokardiyal kontraksiyon zamanında uzama olurken, sistolik ve diyastolik hızlarda değişiklik izlenmedi. Tedavi sonrası sol ventrikül kütlesinde, atım volümünde ve sistemik vasküler rezistansta değişiklik olmadı. Sonuç: SH’lı hastalarda aşikar hipotiroidizme progresyonu ve klinik olarak önemli miyokardiyal disfonksiyon gelişimini önlemek amacıyla L-T4 tedavisi önerilebilir.

🔖

Cite This Article

TURHAN, S., TULUNAY, C., CİN, Ö. M., GÜRSOY, A., KILIÇKAP, M., DİNÇER, İ., CANDEMİR, B., GÜLLÜ, S., EROL, Ç. (2006). Effects of thyroid hormone replacement therapy on left ventricular systolic and diastolic function in patients with subclinical hypothyroidism. MN Kardiyoloji, Cilt: 13 - Sayı: 5, 304–311. https://ajindex.com/articles/297550

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Chu JW, Crapo LM. The treatment of subclinical hypothyroidism is seldom necessary. J Clin Endocrinol Metab 2001;86:4591-4599.
  2. Lupoli G, Biondi B, Mohtedoro D, et al. Systolic time intervals (STI) in various thyroid diseases. Acta Cardiol 1991; 46:87-91.
  3. Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg PA, Lindstedt G. A double-blind cross-over 12-month study of L- thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol 1988; 29:63-75.
  4. Vitale G, Galderisi M, Lupoli GA, et al. Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: Pulsed tissue Doppler. J Clin Endocrinol Metab 2002; 87:4350-55
  5. Monzani F, Di Bello V, Caraccio N, et al. Effect of levothyroxine On cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab 2001; 86:1110-15.
  6. Biondi B, Fazio S, Palmieri EA, et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1999; 84:2064-67.
  7. Brenta G, Mutti LA, Schnitman M, Fretes O, Perrone A, Matute ML Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. Am J cardiol 2003; 91:1327-30.
  8. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-67 Devereux RB. Detection of left ventricular hypertrophy by M- Mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension 1987; 9:19-26. Grossman W. Cardiac catheterization and angiography. 3rd ed. Philadelphia: Lea and Febiger 1986;137. Sahn DL, DeMaria A, Kisslo J, Weyman A. Recommendation regarding quantitation in M-Mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083. Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med 1990; 88:626-32
  9. Ojamaa K, Klein I. In vivo regulation of recombinant cardiac myosin heavy chain gene expression by thyroid hormone. Endocrinology 1993; 132:1002-1010.
  10. Biondi B, Palmieri EA, Lombard! G, Fazio S. Subclinical hypothyroidism and cardiac function. Thyroid 2002; 12:505-10
  11. Forfar JC, Muir AL, Toft AD. Left ve